AstraZeneca diabetes drug gets FDA approval

AstraZeneca diabetes drug gets FDA approval

AstraZeneca said that the US Food and Drug Administration has approved a new formulation of its type-2 diabetes treatment Bydureon. The FDA has approved Astra’s injectable suspension, a new formulation in an improved once-weekly, single-dose autoinjector device for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines in addition to diet and exercise, to improve glycaemic control.